Loading…
LINEZOLID is a brand name for Linezolid, supplied as a solution. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Linezolid Injection (linezolid injection) is indicated for: Treatment of adult patients with the following infections, when caused by susceptible strains of the designated aerobic Gram-positive micro-organisms: Note: Linezolid Injection is not indicated for the treatment of Gram-negative infections. It is critical…
Verbatim from this product's HC label. Tap a section to expand.
5 Post-Market Adverse Reactions 05/2023 7 Warnings and Precautions, Monitoring and Laboratory Tests 09/2024 7 Warnings and Precautions, Musculoskeletal 09/2024 TABLE OF CONTENTS Sections or subsections that are not applicable at the time of authorization are not listed.
RECENT MAJOR LABEL CHANGES .......................................................................................................... 2 TABLE OF CONTENTS ............................................................................................................................
2 PART I: HEALTH PROFESSIONAL INFORMATION ................................................................................... 4 1 INDICATIONS ...........................................................................................................................
1 Pediatrics ............................................................................................................................... 2 Geriatrics ...............................................................................................................................
4 2 CONTRAINDICATIONS .............................................................................................................. 5 4 DOSAGE AND ADMINISTRATION ..............................................................................................
1 Dosing Considerations ........................................................................................................... 2 Recommended Dose and Dosage Adjustment ......................................................................
3 Reconstitution ....................................................................................................................... 4 Administration .......................................................................................................................
5 Missed Dose .......................................................................................................................... 7 5 OVERDOSAGE ..........................................................................................................................
8
5 Post-Market Adverse Reactions 05/2023 7 Warnings and Precautions, Monitoring and Laboratory Tests 09/2024 7 Warnings and Precautions, Musculoskeletal 09/2024 TABLE OF CONTENTS Sections or subsections that are not applicable at the time of authorization are not listed.
RECENT MAJOR LABEL CHANGES .......................................................................................................... 2 TABLE OF CONTENTS ............................................................................................................................
2 PART I: HEALTH PROFESSIONAL INFORMATION ................................................................................... 4 1 INDICATIONS ...........................................................................................................................
1 Pediatrics ............................................................................................................................... 2 Geriatrics ...............................................................................................................................
4 2 CONTRAINDICATIONS .............................................................................................................. 5 4 DOSAGE AND ADMINISTRATION ..............................................................................................
1 Dosing Considerations ........................................................................................................... 2 Recommended Dose and Dosage Adjustment ......................................................................
3 Reconstitution ....................................................................................................................... 4 Administration .......................................................................................................................
, Renal 09/2022
Linezolid Injection is contraindicated for use in patients who have known hypersensitivity to linezolid or any of the other product components. For a complete listing, see 6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING. , phenelzine, isocarboxazid) or within two weeks of taking any such medicinal product.
, dopamine, dobutamine). 4 Drug-Drug Interactions). Linezolid Injection (linezolid injection) Page 6 of 44
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Linezolid in Canada.
Know a brand we are missing in Canada? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
5 Missed Dose .......................................................................................................................... 7 5 OVERDOSAGE ..........................................................................................................................
8 6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING .............................................. 8 7 WARNINGS AND PRECAUTIONS ............................................................................................... 1 Special Populations..............................................................................................................
1 Pregnant Women ................................................................................................................ 2 Breast-feeding .....................................................................................................................
3 Pediatrics ............................................................................................................................. 4 Geriatrics .............................................................................................................................
13 8 ADVERSE REACTIONS ............................................................................................................. 1 Adverse Reaction Overview ................................................................................................
2 Clinical Trial Adverse Reactions ........................................................................................... 3 Less Common Clinical Trial Adverse Reactions ...................................................................
5 Post-Market Adverse Reactions .......................................................................................... 16 9 DRUG INTERACTIONS.............................................................................................................
1 Serious Drug Interactions .................................................................................................... 2 Drug Interactions Overview.................................................................................................
4 Drug-Drug Interactions ........................................................................................................ 5 Drug-Food Interactions .......................................................................................................
6 Drug-Herb Interactions ........................................................................................................ 7 Drug-Laboratory Test Interactions ......................................................................................
22 10 CLINICAL PHARMACOLOGY .................................................................................................... 1 Mechanism of Action...........................................................................................................
3 Pharmacokinetics ................................................................................................................ 22 11 STORAGE, STABILITY AND DISPOSAL ......................................................................................
26 12 SPECIAL HANDLING INSTRUCTIONS........................................................................................ 26 PART II: SCIENTIFIC INFORMATION ....................................................................................................
27 13 PHARMACEUTICAL INFORMATION......................................................................................... 27 14 CLINICAL […]